Based between the University of Glasgow and Kuwait, providing global expertise in reproductive medicine — with a research programme cited more than 39,000 times.
For twenty years I have held the Muirhead Chair of Obstetrics & Gynaecology at the University of Glasgow, leading a research group whose work on ovarian reserve, maternal health and assisted reproduction has informed guidelines from the HFEA, NICE and the ESHRE.
In parallel, I hold the medical directorship of Oxford Medical Kuwait — a tertiary fertility and obstetrics service — and, as Medical Director of Access Fertility, oversee multi-cycle refund programmes across partnered UK clinics.
Alongside this, I act as an instructed expert witness under CPR Part 35 through DRSMN Ltd, with opinion work in fertility treatment, obstetric injury and gynaecological care.
Glasgow is the intellectual base. The research group — supervising doctoral students from the UK and Gulf — uses Scottish Morbidity Records linked to national datasets to examine maternal and child outcomes following assisted conception, obesity, and diabetes in pregnancy.
The appointment also provides liaison with NHS Greater Glasgow & Clyde, and, through the Glasgow Royal Fertility Clinic, a private University of Glasgow / NHS partnership offering IVF to existing patients.
Oxford Medical is the only clinic in Kuwait with a world-class clinical academic at its helm. The service spans consultation, stimulation, IVF/ICSI, PGT, frozen transfer, early pregnancy, antenatal care and delivery — with a bilingual (English / Arabic) clinical toolset hosted on oxmedkw.app.
Practice is shared clinically with Dr Karema Alrashid; consultations are delivered in Khaleeji Arabic where preferred. Expertise in follicular activation and recurrent implantation failure.
A selection drawn from the highest-impact general-medical and specialty journals — work that has shaped IVF practice, obstetric risk prediction and, most recently, the use of machine learning in reproductive medicine.
A ten-paper selection across Nature Medicine, Nature Communications, The Lancet, JAMA, BMJ and Lancet Diabetes & Endocrinology — work that has shaped IVF practice, obstetric risk prediction and the use of machine learning in reproductive medicine.
Full publication list on Google Scholar ↗Commentary and long-form contribution on reproductive health, fertility policy, and maternal medicine — for print, broadcast, and online.
Scientific Advisor. Guidance on novel fertility technologies, clinical performance and outcomes reporting for the UK regulator.
Scientific Advisor. Monthly R/Python KPI pipeline producing interpretive PDF reports benchmarked against Vienna Consensus and US percentile distributions.
Medical Director. Multi-cycle refund programmes and patient-risk modelling across partnered UK clinics.
Advisory outputs on recombinant gonadotrophin strategy, trial design and real-world evidence.
Reproductive biomarker development and assay positioning — AMH, progesterone, hCG.
Advisory work on stimulation pharmacology, real-world outcomes, and digital fertility tools.
Instructed opinion work in fertility, obstetrics and gynaecology — delivered through DRSMN Ltd, with professional indemnity through MDDUS. Reports are structured, evidence-led and never advocate for either party.
Full engagement terms & fee schedule → Terms of Business
To instruct → contact via this site · credentials cited as BSc MBChB PhD MRCOG.